Oberrohrbach, Austria

Walter Spevak




Average Co-Inventor Count = 8.2

ph-index = 6

Forward Citations = 218(Granted Patents)


Location History:

  • Stockerau, AT (1993 - 1997)
  • Oberronhrbach, AT (2007)
  • Oberrohrbach, AT (2003 - 2014)

Company Filing History:


Years Active: 1993-2014

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovations of Walter Spevak: Pioneering Medicinal Chemistry

Introduction

Walter Spevak, an accomplished inventor hailing from Oberrohrbach, Austria, has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 16 patents, Spevak's work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest inventions, Spevak has developed 6-alkynylpyridines, which are known as SMAC mimetics. These compounds are particularly noteworthy for their utility as medicaments in the treatment of diseases characterized by excessive or abnormal cell proliferation, including various forms of cancer. Additionally, he has contributed to the development of pyrimidine derivatives, specifically trisubstituted pyrimidines, which represent a significant leap in the quest for effective treatments.

Career Highlights

Throughout his career, Walter Spevak has been affiliated with notable organizations such as Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim International GmbH. His dedication to advancing pharmaceutical science has led to numerous innovations that continue to shape medicinal research and development.

Collaborations

Spevak has collaborated with esteemed colleagues, including Martin Lenter and Gerald Juergen Roth. These collaborations have further enriched his research, allowing for the exchange of ideas and expertise that enhance the quality of his inventions.

Conclusion

Walter Spevak stands out as a prominent inventor in the field of medicinal chemistry. With his innovative approach and numerous patents, he continues to make strides in developing groundbreaking therapies that address critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…